Recruitment

Recruitment Status
Completed

Summary

Conditions
  • Healthy Volunteers
  • Pharmacokinetics of Digoxin
  • Pharmacokinetics of Isavuconazole
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)

Participation Requirements

Age
Between 18 years and 55 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01582412
Collaborators
Basilea Pharmaceutica International Ltd
Investigators
Study Director: Medical Director Astellas Pharma Global Development